JPRN-UMIN000045345尚未招募未知
Study to evaluate intestinal glucose excretion using 18F-FDG-PET/MR enterography in patients taking imeglimin - PET/MRE study with imeglimin
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. patients with the following contraindications to Buscopan (butyl scopolamine bromide) patients with hemorrhagic colitis patients with angle-closure glaucoma patients with dysuria due to prostatic hypertrophy patients with severe heart disease patients with anesthetic ileus patients with a history of hypersensitivity to this drug 2. patients with dementia or psychiatric disorders 3. patients with possible intestinal perforation or obstruction 4. patients with metals in the body that cannot be tested by PET/MRE 5. pregnant or lactating patients 6. other patients who are judged unsuitable for this study by theinvestigator
研究者
相似试验
已完成
不适用
Study to evaluate intestinal glucose excretion using 18F-FDG-PET/MR enterography in patients not taking metformitype 2 diabetes mellitusJPRN-UMIN000045137Kobe university5
尚未招募
Unknown
Study to evaluate intestinal glucose excretion using 18F-FDG-PET/MR Enterography in patients taking imeglimitype 2 diabetes mellitusJPRN-UMIN000049426Kobe University10
已完成
不适用
Study to evaluate release of glucose toxicity associated with SGLT2 inhibitors administered in patients with metabolic syndrome in type 2 diabetesType 2 diabetesJPRN-UMIN000019660Medical Corporation KYOSOKAI AMC Nishi Umeda Clinic30
已完成
不适用
Clinical study on nutrient excretioJPRN-UMIN000035848FANCL Corporation316
已完成
2 期
Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 WeeksObesityNCT00297180GlaxoSmithKline136